Clinical trial
A Retrospective and Prospective Multicentre Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms (AML/MDS)
NCT04460950 is registered in ClinicalTrials.gov with Gruppo Italiano Malattie EMatologiche dell'Adulto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective and Prospective Multicentre Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms (AML/MDS)
- Lead sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 16, 2020
- Completion date
- March 31, 2025
- Enrollment
- 237 (estimated)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
acute myeloid leukemia, familial acute myeloid leukemia, myelodysplastic syndromes